Attributes | Values |
---|
rdf:type
| |
Description
| - Interactions of DNA with antitumor trans-[PtCl2(E-iminoether)2] were investigated using the methods of molecular biophysics. It has been found that unexpected antitumor effects of this complex are associated with its capability to form DNA-protein cross-links.
- Interactions of DNA with antitumor trans-[PtCl2(E-iminoether)2] were investigated using the methods of molecular biophysics. It has been found that unexpected antitumor effects of this complex are associated with its capability to form DNA-protein cross-links. (en)
- Byly studovány interakce DNA s novým protinádorově účinným komplexem trans-[PtCl2(E-iminoether)2] metodami molekulární biofyziky. Bylo zjištěno, že za neočekávané protinádorové účinky tohoto komplexu jsou zodpovědné můstky, které tato platinová sloučenina vytváří mezi DNA a proteiny. (cs)
|
Title
| - DNA-protein cross-linking by trans-[PtCl2(E-iminoetherú2]. A concept for activation of the trans geometry in platinum antitumor complexes
- DNA-protein cross-linking by trans-[PtCl2(E-iminoetherú2]. A concept for activation of the trans geometry in platinum antitumor complexes (en)
- Tvorba mustků mezi DNA a proteiny komplexem trans-[PtCl2(E-iminoether)] (cs)
|
skos:prefLabel
| - DNA-protein cross-linking by trans-[PtCl2(E-iminoetherú2]. A concept for activation of the trans geometry in platinum antitumor complexes
- DNA-protein cross-linking by trans-[PtCl2(E-iminoetherú2]. A concept for activation of the trans geometry in platinum antitumor complexes (en)
- Tvorba mustků mezi DNA a proteiny komplexem trans-[PtCl2(E-iminoether)] (cs)
|
skos:notation
| - RIV/68081707:_____/03:00032356!RIV06-AV0-68081707
|
http://linked.open.../vavai/riv/strany
| |
http://linked.open...avai/riv/aktivita
| |
http://linked.open...avai/riv/aktivity
| - P(GA305/02/1552), P(KJB5004301), P(OC D20.004), P(OC D21.001), Z(AV0Z50040507)
|
http://linked.open...iv/cisloPeriodika
| |
http://linked.open...vai/riv/dodaniDat
| |
http://linked.open...aciTvurceVysledku
| |
http://linked.open.../riv/druhVysledku
| |
http://linked.open...iv/duvernostUdaju
| |
http://linked.open...titaPredkladatele
| |
http://linked.open...dnocenehoVysledku
| |
http://linked.open...ai/riv/idVysledku
| - RIV/68081707:_____/03:00032356
|
http://linked.open...riv/jazykVysledku
| |
http://linked.open.../riv/klicovaSlova
| - antitumor drug; DNA; protein (en)
|
http://linked.open.../riv/klicoveSlovo
| |
http://linked.open...odStatuVydavatele
| - GB - Spojené království Velké Británie a Severního Irska
|
http://linked.open...ontrolniKodProRIV
| |
http://linked.open...i/riv/nazevZdroje
| |
http://linked.open...in/vavai/riv/obor
| |
http://linked.open...ichTvurcuVysledku
| |
http://linked.open...cetTvurcuVysledku
| |
http://linked.open...vavai/riv/projekt
| |
http://linked.open...UplatneniVysledku
| |
http://linked.open...v/svazekPeriodika
| |
http://linked.open...iv/tvurceVysledku
| - Brabec, Viktor
- Kašpárková, Jana
- Malina, Jaroslav
- Nováková, Olga
- Natile, G.
|
http://linked.open...n/vavai/riv/zamer
| |
issn
| |
number of pages
| |